Greta Carioli

Ropeginterferon Alfa-2b Versus Standard Therapy for Low-Risk Patients with Polycythemia Vera. Final Results of Low-PV Randomized Phase II Trial

T. Barbui, G. Tognoni, A. Patriarca, 2022, Blood.

Paediatric porto‐sinusoidal vascular disease: Two different clinical phenotypes with subtle histological differences

L. D’Antiga, A. Di Giorgio, G. Maggiore, 2023, Liver international : official journal of the International Association for the Study of the Liver.

Clonal Hematopoiesis in Myeloproliferative Neoplasms Confers a Predisposition to both Thrombosis and Cancer

A. Gavazzi, T. Barbui, E. Sciatti, 2023, Current Hematologic Malignancy Reports.

Ropeginterferon versus Standard Therapy for Low-Risk Patients with Polycythemia Vera.

T. Barbui, G. Tognoni, A. Patriarca, 2023, NEJM evidence.

Liver Transplantation in Patients with Portal Vein Thrombosis: Revisiting Outcomes According to Surgical Techniques

M. Cescon, M. Ravaioli, A. Siniscalchi, 2023, Journal of clinical medicine.

Adherence of ticagrelOr in real world patients with aCute coronary syndrome: The AD-HOC study

A. Gavazzi, M. Senni, F. Amico, 2022, International journal of cardiology. Heart & vasculature.

Increased prevalence of autoimmune thyroid disease after COVID-19: A single-center, prospective study

T. Barbui, R. Trevisan, G. Carioli, 2023, Frontiers in Endocrinology.